The Morning Call
A significant breakthrough may have been recorded in the search for effective treatment and cure for the deadly HIV virus. Scientists say a new HIV vaccine candidate has been trialled in humans and monkeys, with promising results.
Nearly 400 healthy, uninfected adults are reported to have mounted an immune response against the vaccine and tolerated it well, according to the latest study published in The Lancet.
It’s a quest that’s been nearly 40 years in the making. Lead researcher Dan Barouch from Harvard Medical School said the study was an “important milestone” in HIV research, but that the results should be interpreted with caution.
So are we one step closer to finding effective treatment for HIV?
Go to video
Africa CDC endorses Morocco's Mpox test
01:37
South Africa's refurbished Digital Dome set to open in February 2025
01:15
WHO: Mpox cases in South Kivu may be 'plateauing', but DRC seeing a 'general rising trend' in cases
01:50
Zipline partners Nigeria for improved healthcare delivery
01:05
Nigeria to roll out a new malaria vaccine
00:53
Bavarian Nordic mpox vaccine gets green light from WHO for use in adolescents